Onconetix (ONCO) EPS (Diluted) (2021 - 2026)
Onconetix (ONCO) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.15 |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | -1.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.28 |
| Mar 31, 2026 | -67.06 |
| Dec 31, 2025 | 302.32 |
| Sep 30, 2025 | -312.49 |
| Jun 30, 2025 | -237.91 |
| Mar 31, 2025 | -2,272.74 |
| Dec 31, 2024 | -45,889.70 |
| Sep 30, 2024 | -12,467.12 |
| Jun 30, 2024 | -109,211.48 |
| Mar 31, 2024 | -85,527.48 |
| Dec 31, 2023 | -221,295.76 |
| Sep 30, 2023 | -51,911.73 |
| Jun 30, 2023 | -73,034.79 |
| Mar 31, 2023 | -30,283.45 |
| Dec 31, 2022 | -44,693.40 |
| Sep 30, 2022 | -46,031.69 |
| Jun 30, 2022 | -60,064.54 |
| Mar 31, 2022 | -58,568.11 |
| Dec 31, 2021 | -71,974.84 |
| Sep 30, 2021 | -67,486.53 |